Kadioglu A, Tefekli A, Koksal T et al: Treatment of Peyronie's disease with oral colchicine:long-term results and predictive parameters of successful outcome
Notably, combination treatment with lower dose of metformin (0.1 mmol/L) and liraglutide (3 nmol/L) had a significant protective effect on the PA-induced upregulation of ROS production and reduction of NO level and p-eNOS protein level (Fig
Many patients do well with smaller portions of lean meat, fish, eggs, Greek yogurt, cottage cheese, tofu, beans, or protein shakes when appropriate
Ribechini E, Hutchinson JA, Hergovits S, Heuer M, Lucas J, Schleicher U, Jordn Garrote AL, Potter SJ, Riquelme P, Brackmann H, Mller N, Raifer H, Berberich I, Huber M, Beilhack A, Lohoff M, Bogdan C, Eyrich M, Hermanns HM, Geissler EK, Lutz MB